5907 GENES FOUND
Show / hide columns
XML |
RDF |
TSV |
Page next »
IH abundance (Normal Tissue)
x
RNA abundance (Normal Tissue)
x
A4GALT Alpha 1,4-galactosyltransferase
Mitochondria Cervical cancer: 2.48e-4 Mixed
A4GNT Alpha-1,4-N-acetylglucosaminyltransferase
Tissue enriched 8 stomach: 24.6
AAAS Achalasia, adrenocortical insufficiency, alacrimia
Nuclear membrane Renal cancer: 2.93e-4 Expressed in all
AACS Acetoacetyl-CoA synthetase
Vesicles Expressed in all
AADACL4 Arylacetamide deacetylase-like 4 N/A
Not detected
AASDH Aminoadipate-semialdehyde dehydrogenase
Mixed
AASS Aminoadipate-semialdehyde synthase
Vesicles Liver cancer: 9.81e-4 Mixed
AATK Apoptosis-associated tyrosine kinase
Mitochondria Tissue enhanced cerebral cortex: 36.5 duodenum: 24.0
ABAT 4-aminobutyrate aminotransferase
Mitochondria Renal cancer: 5.44e-8 Liver cancer: 5.36e-5 Lung cancer: 5.93e-4 Tissue enhanced cerebral cortex: 165.0 kidney: 134.3 liver: 175.2
ABC7-42404400C24.1
Golgi apparatus Tissue enhanced cerebral cortex: 13.8 lung: 19.5
ABCA1 ATP-binding cassette, sub-family A (ABC1), member 1
Nucleoplasm Mixed
ABCA10 ATP-binding cassette, sub-family A (ABC1), member 10
Mixed
ABCA13 ATP-binding cassette, sub-family A (ABC1), member 13
Vesicles Tissue enriched 10 bone marrow: 29.4
ABCA2 ATP-binding cassette, sub-family A (ABC1), member 2
Tissue enriched 6 cerebral cortex: 98.2
ABCA3 ATP-binding cassette, sub-family A (ABC1), member 3
Nucleoplasm Tissue enhanced lung: 135.8
ABCA5 ATP-binding cassette, sub-family A (ABC1), member 5
Pancreatic cancer: 9.97e-5 Expressed in all
ABCA6 ATP-binding cassette, sub-family A (ABC1), member 6
Nucleoplasm Liver cancer: 3.29e-4 Tissue enhanced liver: 41.4
ABCA7 ATP-binding cassette, sub-family A (ABC1), member 7
Golgi apparatus Endometrial cancer: 1.12e-4 Colorectal cancer: 7.26e-4 Mixed
ABCA8 ATP-binding cassette, sub-family A (ABC1), member 8
Nucleoplasm Mixed
ABCA9 ATP-binding cassette, sub-family A (ABC1), member 9
Mixed
ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1
Nucleoplasm Renal cancer: 2.95e-4 Pancreatic cancer: 3.33e-4 Tissue enhanced adrenal gland: 138.6 small intestine: 83.9
ABCB10 ATP-binding cassette, sub-family B (MDR/TAP), member 10
Expressed in all
ABCB11 ATP-binding cassette, sub-family B (MDR/TAP), member 11
Nucleoplasm Tissue enriched 13 liver: 19.1
ABCB4 ATP-binding cassette, sub-family B (MDR/TAP), member 4
Nucleoplasm Tissue enriched 6 liver: 69.2
ABCB5 ATP-binding cassette, sub-family B (MDR/TAP), member 5 N/A
Tissue enriched 7 epididymis: 31.7
ABCB6 ATP-binding cassette, sub-family B (MDR/TAP), member 6 (Langereis blood group)
Nucleoplasm Renal cancer: 1.52e-7 Liver cancer: 9.45e-7 Expressed in all
ABCB7 ATP-binding cassette, sub-family B (MDR/TAP), member 7
Mitochondria Renal cancer: 5.31e-6 Expressed in all
ABCB8 ATP-binding cassette, sub-family B (MDR/TAP), member 8
Nucleus Pancreatic cancer: 3.34e-4 Renal cancer: 5.88e-4 Head and neck cancer: 5.91e-4 Expressed in all
ABCB9 ATP-binding cassette, sub-family B (MDR/TAP), member 9
Vesicles Glioma: 4.62e-4 Tissue enhanced testis: 23.9
ABCC1 ATP-binding cassette, sub-family C (CFTR/MRP), member 1
Plasma membrane Renal cancer: 1.55e-6 Liver cancer: 5.42e-5 Mixed
ABCC10 ATP-binding cassette, sub-family C (CFTR/MRP), member 10
Renal cancer: 1.90e-4 Expressed in all
ABCC11 ATP-binding cassette, sub-family C (CFTR/MRP), member 11
Tissue enriched 11 breast: 63.2
ABCC12 ATP-binding cassette, sub-family C (CFTR/MRP), member 12 N/A
Tissue enhanced testis: 2.9
ABCC2 ATP-binding cassette, sub-family C (CFTR/MRP), member 2
Renal cancer: 1.93e-5 Group enriched 10 duodenum: 44.7 gallbladder: 42.8 kidney: 20.8 liver: 67.6 small intestine: 50.5
ABCC3 ATP-binding cassette, sub-family C (CFTR/MRP), member 3
Plasma membrane Renal cancer: 4.68e-6 Pancreatic cancer: 9.57e-4 Mixed
ABCC4 ATP-binding cassette, sub-family C (CFTR/MRP), member 4
Nucleoli Renal cancer: 2.25e-10 Endometrial cancer: 9.89e-4 Tissue enhanced prostate: 68.5
ABCC5 ATP-binding cassette, sub-family C (CFTR/MRP), member 5
Nucleus Liver cancer: 6.78e-8 Prostate cancer: 3.40e-4 Expressed in all
ABCC6 ATP-binding cassette, sub-family C (CFTR/MRP), member 6
Plasma membrane Liver cancer: 3.82e-4 Tissue enhanced kidney: 15.2 liver: 19.1
ABCC8 ATP-binding cassette, sub-family C (CFTR/MRP), member 8
Nucleoli Tissue enhanced cerebral cortex: 11.7
ABCC9 ATP-binding cassette, sub-family C (CFTR/MRP), member 9
Nucleoplasm Renal cancer: 1.85e-5 Mixed
ABCD3 ATP-binding cassette, sub-family D (ALD), member 3
Peroxisomes Colorectal cancer: 1.16e-5 Renal cancer: 4.84e-5 Expressed in all
ABCD4 ATP-binding cassette, sub-family D (ALD), member 4
Expressed in all
ABCE1 ATP-binding cassette, sub-family E (OABP), member 1
Cytosol Pancreatic cancer: 1.88e-4 Liver cancer: 6.29e-4 Colorectal cancer: 8.69e-4 Expressed in all
ABCG1 ATP-binding cassette, sub-family G (WHITE), member 1
Golgi apparatus Renal cancer: 7.16e-6 Expressed in all
ABCG2 ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
Nucleus Tissue enhanced small intestine: 116.1
ABCG4 ATP-binding cassette, sub-family G (WHITE), member 4 N/A
Group enriched 6 cerebral cortex: 6.6 parathyroid gland: 4.0 testis: 5.1
ABCG5 ATP-binding cassette, sub-family G (WHITE), member 5
Nucleus Liver cancer: 2.60e-5 Group enriched 32 duodenum: 58.0 liver: 28.3 small intestine: 57.4
ABCG8 ATP-binding cassette, sub-family G (WHITE), member 8
Vesicles Group enriched 25 duodenum: 51.4 liver: 34.1 small intestine: 56.7
ABHD1 Abhydrolase domain containing 1
Tissue enriched 17 testis: 29.9
ABHD12 Abhydrolase domain containing 12
Cervical cancer: 1.30e-5 Breast cancer: 3.81e-5 Liver cancer: 7.18e-4 Expressed in all
Page next »
